HK-listed Jacobio Pharmaceuticals climbs on share buyback plan
08/06/2026 04:21
BUZZ-HK-listed Jacobio Pharmaceuticals climbs on share buyback plan ** Shares of Jacobio Pharmaceuticals Group 1167.HK climb 4.6% to HK$4.33, on track for the biggest one-day pct gain since May 29
** Stock touches the highest since June 4
** Chinese new drug developer plans to repurchase up to 78.37 mln shares, or 10% of the issued share capital, in the open market for up to HK$100 mln ($12.76 mln)
** Share repurchase will be funded by the company's own financial resources
** YTD, stock down 33.1%, Hang Seng Biotech Index .HSBIO down 14.8%
($1 = 7.8343 Hong Kong dollars)
(Reporting by Donny Kwok)
Recent news on Jacobio Pharmaceuticals
See all newsBrief: Jacobio Pharmaceuticals Appoints Xiaojie Wang As Vice Chairperson
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan